BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 801583)

  • 1. Clinical use of buprenorphine in chronic administration.
    Adriaensen H; Van De Walle J
    Acta Anaesthesiol Belg; 1976; 27(3):187-91. PubMed ID: 801583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butorphanol, a new intravenous analgesic: double-blind comparison with morphine sulfate in postoperative patients with moderate or severe pain.
    Delpizzo A
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):221-32. PubMed ID: 822981
    [No Abstract]   [Full Text] [Related]  

  • 3. A long-term open, clinical and pharmacokinetic assessment of sublingual buprenorphine in patients suffering from chronic pain.
    Adriaensen H; Mattelaer B; Vanmeenen H
    Acta Anaesthesiol Belg; 1985 Mar; 36(1):33-40. PubMed ID: 4013631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine as postoperative analgesic.
    Rolly G; Versichelen L
    Acta Anaesthesiol Belg; 1976; 27(3):183-6. PubMed ID: 801582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of oral meptazinol in postoperative pain.
    Paymaster NJ
    Acta Anaesthesiol Belg; 1976; 27(3):159-70. PubMed ID: 801581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sublingual buprenorphine tablets: initial clinical experiences in long-term therapy of cancer pain].
    Zenz M; Piepenbrock S; Tryba M; Klauke W; Everlien M
    Fortschr Med; 1983 Feb; 101(5):191-4. PubMed ID: 6403440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meptazinol--a new analgesic effects on hemodynamic stability.
    Budd K
    Acta Anaesthesiol Belg; 1976; 27(3):151-8. PubMed ID: 801580
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First experience with a new analgesic drug: buprenorphine.
    Rolly G; Versichelen L
    Acta Anaesthesiol Belg; 1976; 27 suppl():134-42. PubMed ID: 1015212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind oral analgesic study of butorphanol in episiotomy pain: a comparison with codeine and placebo.
    Levin HM
    J Int Med Res; 1978; 6(1):24-33. PubMed ID: 342301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of a long-acting analgesic, buprenorphine on cancer pain--a single-blind crossover comparison with pentazocine].
    Taguchi T
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):250-7. PubMed ID: 7184401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term therapy of cancer pain. A controlled study on buprenorphine].
    Zenz M; Piepenbrock S; Tryba M; Glocke M; Everlien M; Klauke W
    Dtsch Med Wochenschr; 1985 Mar; 110(12):448-53. PubMed ID: 2579784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of butorphanol tartrate in cancer patients: evaluation for analgesic effects and safety on the basis of long term administration].
    Konno K; Nakai Y; Ebina A; Sato M; Nagai K; Hayashi I; Ito T
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1634-45. PubMed ID: 6347086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of an oral analgesic, Z.424, in patients with chronic pain.
    Martinetti L; Lodola E; Monafo V; Ferrari V
    J Clin Pharmacol J New Drugs; 1970; 10(6):390-9. PubMed ID: 4920491
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brompton mixture versus morphine solution given orally: effects on pain.
    Melzack R; Mount BM; Gordon JM
    Can Med Assoc J; 1979 Feb; 120(4):435-8. PubMed ID: 376079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy: analgetic drugs--the potent analgetics.
    Vandam LD
    N Engl J Med; 1972 Feb; 286(5):249-53. PubMed ID: 4550456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients].
    Dini D; Fassio T; Gottlieb A; Gini M
    Minerva Med; 1986 Jan; 77(3-4):93-104. PubMed ID: 3511410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of tramadol in an open clinical trial (author's transl)].
    Schenck EG; Arend I
    Arzneimittelforschung; 1978; 28(1a):209-12. PubMed ID: 343790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.